Genepeeks And Donor Concierge Announce Strategic Partnership Agreement

CAMBRIDGE, Mass.--(BUSINESS WIRE)--GenePeeks, Inc., a computational genomics company focused on unique identification and interpretation of genetic disease risk, and Donor Concierge, a leading egg donor and surrogate search service for intended parents, today announced a new strategic partnership.

GenePeeks’ goal of global access to their next-generation preconception test is further advanced by this new agreement with Donor Concierge, who assists families around the world in finding their ideal egg donor or surrogate through its vast network of fertility agencies and clinic partners.

“Donor Concierge is a fantastic addition to our strong and growing list of partners,” said Anne Morriss, Co-founder and Chief Executive Officer of GenePeeks. “With its outstanding record of growth, impact and integrity, Donor Concierge will help increase global access to our advanced analytics platform.”

Gail Sexton Anderson, Founder and Chief Executive Officer of Donor Concierge stated, “We are excited to announce our partnership with GenePeeks, a huge breakthrough in the field of third-party assisted fertility. GenePeeks takes so much of the guessing and stress out of choosing a donor. Doing genetic screening with GenePeeks means that intended parents can move forward with a greater sense of confidence that they've found the right donor to help them build their family.”

About GenePeeks’ Screening Product
GenePeeks’ preconception product is based on the company’s screening technology which uniquely integrates simulated DNA information from both genetic contributors to predict the genome of a future child. For every variant in these hypothetical genomes, the company’s proprietary variant interpretation pipeline computes a Variant Gene Dysfunction (VGD) score that predicts gene function and associated disease risk. This automated, CLIA certified process allows GenePeeks to surface disease risk with increased sensitivity and go beyond the limits of the clinical data sets, evaluating variants that remain uncharacterized by other genetic tests.

About GenePeeks’ Computational Technology
GenePeeks is a computational genomics company transforming how genetic disease risk is identified and interpreted. GenePeeks’ patented technology simulates the complex genetic interactions that occur naturally in human reproduction and the inheritance of disease risk. The company’s next-generation approach addresses the primary challenges of genomic analysis today, including the pervasiveness of rare and novel disease-causing mutations, the high incidence of variants of unknown or uncertain significance (VUS), and the population bias embedded in clinical literature and databases. GenePeeks offers its physician-ordered services through its CLIA certified clinical laboratory.

GenePeeks is privately held, with corporate offices in Cambridge, Mass. For more information, visit www.genepeeks.com

GenePeeks’ next-generation screening technology is available today. For more information about becoming a partner, please contact support@genepeeks.com

About Donor Concierge
Donor Concierge provides a personalized concierge service for intended parents searching for egg donors, sperm donors and surrogates. The expert team at Donor Concierge has a record of outstanding results helping families match with the best candidates for their family. Through its extensive network of leading egg donation and surrogacy programs, Donor Concierge tailors each search to intended parents’ individual requirements. Donor Concierge case managers are compassionate and knowledgeable with personal experience of fertility treatment. Donor Concierge works closely with more than 100 agencies and fertility professionals across the United States, bringing unique insights and understanding of the third-party fertility industry, as they help intended parents navigate their journey towards finding the right donor or surrogate mother match.

www.donorconcierge.com/